Current measures of metabolic heterogeneity within cervical cancer do not predict disease outcome
Abstract Background A previous study evaluated the intra-tumoral heterogeneity observed in the uptake read more of F-18 fluorodeoxyglucose (FDG) in pre-treatment positron emission tomography (PET) scans of cancers of the uterine cervix as an indicator of disease outcome.This was done via a novel statistic which ostensibly measured the spatial varia